Avantor, Inc. Increase (Decrease) in Other Operating Assets and Liabilities, Net
Avantor, Inc. (AVTR) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $37.10 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-04-29
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was $37.10M, a 27.49% increase year-over-year.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was $116.80M, a 15.99% increase year-over-year.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$25.50M.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-06-30 was $23.80M, a 720.69% increase year-over-year.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $144.20M, a 282.49% increase from fiscal 2024.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was $37.70M.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was -$48.60M, a 127.11% decline from fiscal 2022.
- Avantor, Inc. increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was $179.30M.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $37.10M 10-Q · filed 2026-04-29 | $153.90M derived: sum of 2 quarters · filed 2026-04-29 | $128.40M derived: sum of 3 quarters · filed 2026-04-29 | $152.20M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-12-31 | $116.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $91.30M derived: sum of 2 quarters · filed 2026-02-11 | $115.10M derived: sum of 3 quarters · filed 2026-02-11 | $144.20M 10-K · filed 2026-02-11 | |||
| 2025-09-30 | -$25.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$1.70M derived: sum of 2 quarters · filed 2025-10-29 | $27.40M 10-Q · filed 2025-10-29 | $128.10M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-06-30 | $23.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $52.90M 10-Q · filed 2025-08-01 | $153.60M derived: sum of 3 quarters · filed 2026-04-29 | $97.00M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-03-31 | $29.10M 10-Q · filed 2026-04-29 | $129.80M derived: sum of 2 quarters · filed 2026-04-29 | $73.20M derived: sum of 3 quarters · filed 2026-04-29 | $76.10M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $100.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $44.10M derived: sum of 2 quarters · filed 2026-02-11 | $47.00M derived: sum of 3 quarters · filed 2026-02-11 | $37.70M 10-K · filed 2026-02-11 | |||
| 2024-09-30 | -$56.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$53.70M derived: sum of 2 quarters · filed 2025-10-29 | -$63.00M 10-Q · filed 2025-10-29 | -$150.10M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$6.40M 10-Q · filed 2025-08-01 | -$93.50M derived: sum of 3 quarters · filed 2026-02-11 | -$89.30M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-03-31 | -$9.30M 10-Q · filed 2025-04-25 | -$96.40M derived: sum of 2 quarters · filed 2026-02-11 | -$92.20M derived: sum of 3 quarters · filed 2026-02-11 | -$13.80M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | -$87.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$82.90M derived: sum of 2 quarters · filed 2026-02-11 | -$4.50M derived: sum of 3 quarters · filed 2026-02-11 | -$48.60M 10-K · filed 2026-02-11 | |||
| 2023-09-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $82.60M derived: sum of 2 quarters · filed 2024-10-25 | $38.50M 10-Q · filed 2024-10-25 | $119.80M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2023-06-30 | $78.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $34.30M 10-Q · filed 2024-07-26 | $115.60M derived: sum of 3 quarters · filed 2025-02-07 | $98.20M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2023-03-31 | -$44.10M 10-Q · filed 2024-04-26 | $37.20M derived: sum of 2 quarters · filed 2025-02-07 | $19.80M derived: sum of 3 quarters · filed 2025-02-07 | $89.00M derived: sum of 4 quarters · filed 2025-02-07 | |||
| 2022-12-31 | $81.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $63.90M derived: sum of 2 quarters · filed 2025-02-07 | $133.10M derived: sum of 3 quarters · filed 2025-02-07 | $179.30M 10-K · filed 2025-02-07 | |||
| 2022-09-30 | -$17.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $51.80M derived: sum of 2 quarters · filed 2023-10-27 | $98.00M 10-Q · filed 2023-10-27 | $61.60M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-06-30 | $69.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $115.40M 10-Q · filed 2023-07-28 | $79.00M derived: sum of 3 quarters · filed 2024-02-14 | $48.30M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-03-31 | $46.20M 10-Q · filed 2023-04-28 | $9.80M derived: sum of 2 quarters · filed 2024-02-14 | -$20.90M derived: sum of 3 quarters · filed 2024-02-14 | -$16.60M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | -$36.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$67.10M derived: sum of 2 quarters · filed 2024-02-14 | -$62.80M derived: sum of 3 quarters · filed 2024-02-14 | -$56.90M 10-K · filed 2024-02-14 | |||
| 2021-09-30 | -$30.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$26.40M derived: sum of 2 quarters · filed 2022-10-28 | -$20.50M 10-Q · filed 2022-10-28 | -$55.90M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $10.20M 10-Q · filed 2022-07-29 | -$25.20M derived: sum of 3 quarters · filed 2023-02-14 | -$66.90M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $5.90M 10-Q · filed 2022-04-29 | -$29.50M derived: sum of 2 quarters · filed 2023-02-14 | -$71.20M derived: sum of 3 quarters · filed 2023-02-14 | -$80.30M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | -$35.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$77.10M derived: sum of 2 quarters · filed 2023-02-14 | -$86.20M derived: sum of 3 quarters · filed 2023-02-14 | -$110.70M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | -$41.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$50.80M derived: sum of 2 quarters · filed 2021-10-29 | -$75.30M 10-Q · filed 2021-10-29 | -$62.30M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-06-30 | -$9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$33.60M 10-Q · filed 2021-07-30 | -$20.60M derived: sum of 3 quarters · filed 2022-02-11 | -$31.50M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-03-31 | -$24.50M 10-Q · filed 2021-04-28 | -$11.50M derived: sum of 2 quarters · filed 2022-02-11 | -$22.40M derived: sum of 3 quarters · filed 2022-02-11 | $30.30M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2019-12-31 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $2.10M derived: sum of 2 quarters · filed 2022-02-11 | $54.80M derived: sum of 3 quarters · filed 2022-02-11 | $49.30M 10-K · filed 2022-02-11 | $51.70M 10-K · filed 2020-02-14 | ||
| 2019-09-30 | -$10.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $41.80M derived: sum of 2 quarters · filed 2020-10-27 | $36.30M 10-Q · filed 2020-10-27 | -$22.20M 10-Q · filed 2019-11-05 | $81.00M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-06-30 | $52.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $47.20M 10-Q · filed 2020-07-29 | $49.00M 10-Q · filed 2019-08-06 | $91.90M derived: sum of 3 quarters · filed 2021-02-16 | $1.90M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-03-31 | -$5.50M 10-Q · filed 2020-04-29 | $39.20M derived: sum of 2 quarters · filed 2021-02-16 | -$50.80M derived: sum of 3 quarters · filed 2021-02-16 | ||||
| 2018-12-31 | $44.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$45.30M derived: sum of 2 quarters · filed 2021-02-16 | -$3.70M 10-K · filed 2021-02-16 | -$1.30M 10-K · filed 2020-02-14 | |||
| 2018-09-30 | -$90.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$48.40M 10-Q · filed 2019-11-05 | |||||
| 2018-06-30 | $41.60M 10-Q · filed 2019-08-06 | ||||||
| 2017-12-31 | -$7.00M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |